Summary of the Conference Call for Meiya Optoelectronics Company Overview - **Company**: Meiya Optoelectronics - **Industry**: Medical Equipment and Sorting Machines Key Points Financial Performance and Business Segments - In 2025, the medical segment's revenue declined by nearly 10%, but the decline was narrowed through active reduction of low-margin product sales, stabilizing the gross margin and achieving excellent profit performance [2][3] - The sorting machine business accounted for over 70% of total revenue, with the recycling resource sorting business exceeding 300 million yuan in revenue and maintaining double-digit growth, becoming a core growth engine [2][3] - The export business of CBCT (Cone Beam Computed Tomography) entered a period of rapid growth, with export volume doubling to over 200 units in 2025, although it currently accounts for less than 10% of total revenue [2][3] - Contract liabilities increased by over 40% year-on-year by the end of 2025, indicating good growth in orders on hand; the delivery cycle for sorting machines is 1-2 weeks, and for CBCT, it is 2-4 weeks, reflecting high turnover efficiency [2][3] Digital Transformation and New Products - Digital transformation is showing initial results, with revenue from the sorting machine "Meiya Smart Link" exceeding 20 million yuan, achieving nearly double growth; the oral "Smart Cloud" platform has over 10,000 users and has initiated differentiated charging [2][3] - New products in the large medical sector, such as mobile CT and surgical navigation, achieved a breakthrough from 0 to 1 in 2025, with plans for steady market advancement in 2026 aimed at promoting the localization of high-end imaging equipment [2][3] Dividend Policy and Future Outlook - The company maintains a high dividend policy, with cumulative dividends of nearly 5 billion yuan over 13 years, which is six times the IPO fundraising amount; the performance target for 2026 is expected to grow by 17%-18%, with strong expectations for dividend stability [2][3][11] Market Conditions and Industry Trends - The domestic oral industry is currently in a low point, but signs of gradual recovery are emerging, with terminal customers shifting from cautious pessimism to cautious optimism [4] - The company is committed to investing in oral technology research and digitalization despite the industry's challenges, anticipating gradual recovery in 2026 [4] - The update cycle for CBCT devices installed before the pandemic (2018-2019) is expected to begin in 2026, with some old customers already starting to purchase or update equipment [4] Product Development and Competitive Position - The newly launched oral microscope product complements the company's oral imaging equipment product line, with good development potential, although specific pricing and market expectations are still uncertain [5] - The "Smart Cloud" platform is currently in a loss-making state, with a long-term goal of achieving breakeven or reduced losses, depending on the recovery of the oral industry [6] - The sorting machine business has shown unexpected performance, driven by improved engineering design capabilities, the popularity of intelligent production, and optimized sales policies [7][8] Export Strategy and Market Expansion - The company has begun to focus on overseas medical markets, with CBCT exports reaching over 200 units in 2025, and plans to increase investment in overseas markets for both sorting machines and medical devices [10][12][13] - The gross margin for overseas business is typically about 10 percentage points higher than domestic, attributed to pricing strategies rather than specific product structures [12][13] - The company is building a dealer network for CBCT products in overseas markets, which requires a gradual process of engagement and collaboration with local agents [15] Conclusion - The company is optimistic about the future, focusing on enhancing product competitiveness and optimizing marketing strategies to achieve stable growth despite global uncertainties [3][4][10]

Investment Rating - The investment rating for the company is maintained at "Buy" with a target price of RMB 22.50 [1]. Core Insights - The company reported a revenue of RMB 2.4 billion for 2025, a year-on-year increase of 4%, and a net profit attributable to shareholders of RMB 720 million, up 11% year-on-year. The revenue for Q4 2025 was RMB 710 million, down 3% year-on-year, while the net profit for the same quarter was RMB 200 million, an increase of 0.6% year-on-year [1][2]. - The company is focusing on high-quality customers and product upgrades, which have driven revenue growth in 2025. The revenue from color sorting machines, medical devices, and industrial inspection increased by 8%, -10%, and 3.5% year-on-year, respectively. The overseas revenue grew by 10% year-on-year [2][3]. - The gross margin for 2025 was 53.92%, and the net margin was 29.88%, reflecting improvements of 3.49 and 1.79 percentage points year-on-year, respectively. The Q4 2025 gross margin reached 56.24%, the highest in the past decade [3]. - The company achieved a net cash inflow from operating activities of RMB 962 million in 2025, a 10% increase year-on-year, and has maintained a high dividend payout ratio, distributing RMB 7 per 10 shares for four consecutive years, resulting in a dividend yield of nearly 4% based on the closing price on March 30 [4]. - The profit forecast for 2026-2028 has been slightly adjusted upwards, with expected net profits of RMB 796 million, RMB 868 million, and RMB 931 million, respectively. The corresponding PE ratios are projected to be 20, 19, and 17 times [5].

Summary of Meiya Optoelectronics Conference Call Company Overview - **Company**: Meiya Optoelectronics - **Industry**: Medical Devices and Resource Recycling Key Points Financial Performance - In the first half of 2025, Meiya Optoelectronics reported a revenue growth of **10%** and a net profit increase of **11%** [3] - The color sorting machine segment showed a particularly strong performance with a **15%** growth in business and an improvement in gross margin [3] - The medical segment stabilized after a decline, with revenue remaining flat compared to the previous year, although gross margin decreased [3] Business Segments - The oral healthcare business revenue was approximately flat year-on-year, with a slight decline of **0.5%** [6] - The recycling resource business accounted for **20%** of the color sorting machine's total revenue, showing rapid growth in the first half of 2025 [15] - The overseas medical device business has registered in over **50** countries, achieving double-digit growth despite challenges [4][20] Strategic Initiatives - Meiya Optoelectronics is focused on enhancing core competitiveness and flexible marketing strategies to expand sales in the oral healthcare sector [9] - The company is leveraging AI and digital technologies to improve production efficiency and effectiveness, including the launch of the AI-powered Meiya Engine for oral CBCT [11] - The company plans to maintain a high dividend policy while investing **185 million yuan** in a new project, ensuring cash flow remains unaffected [4][25] Market Outlook - The company expects to maintain steady growth in the second half of 2025, despite potential pressures from market conditions [5] - The domestic oral healthcare industry is currently in a downturn, but Meiya Optoelectronics believes in a positive future driven by economic recovery and demographic trends [8][9] - The color sorting machine segment is anticipated to continue benefiting from increasing market demand and improved product competitiveness [23] Challenges and Responses - The domestic oral healthcare market faces intense competition and low pricing, but Meiya Optoelectronics is confident in its market position and risk resilience [8] - The company is committed to high-quality development and will not sacrifice margins for market share [9] Future Developments - The company is optimistic about the future of its mobile CT devices, which are in the early stages of market introduction [21] - Meiya Optoelectronics is evaluating its digital solutions for rice processing, which are expected to gain traction as the industry moves towards greater automation [13] Additional Insights - The gross margin for the recycling resource business is notably high, indicating strong profitability potential [19] - The company is actively working on enhancing its brand influence and service capabilities to compete effectively in the market [9] This summary encapsulates the key insights from the conference call, highlighting the company's performance, strategic initiatives, market outlook, and challenges faced in the current environment.